Form 4: Harvard Bioscience CFO Sells Shares to Cover Tax Obligations

Harvard Bioscience's Chief Financial Officer, Jennifer Cote, sold shares to cover tax obligations related to vested restricted stock units.

Summary

• Jennifer Cote, the Chief Financial Officer of Harvard Bioscience, sold 4,731 shares of common stock at $1.98 per share on December 29, 2024.
• An additional 3,797 shares were sold at the same price on the same day.
• These sales were to cover tax withholding obligations related to restricted stock units (RSUs) that vested on December 29, 2024.
• Following these transactions, Ms. Cote beneficially owns 160,210 shares of common stock, including unvested RSUs.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across various industries.
• Many companies use RSUs as part of their compensation packages, leading to similar transactions by executives at other firms.
• The sale of shares by Jennifer Cote is consistent with standard practices for executives receiving equity compensation.

Stakeholder Impact

• The stock sale by the CFO may have a minor impact on the stock price, but it is not expected to be significant.
• The transaction is a normal part of executive compensation and should not have a material impact on other stakeholders.

Key Dates

Keywords

Harvard Bioscience, Jennifer Cote, CFO, stock sale, restricted stock units, RSU, tax obligations, insider trading